Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study

Clinical trial NCT07739511 · RECRUITING

Trial details

NCT number: NCT07739511
Sponsor: Liu Shu
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2 + Breast Cancer

Start date: 2026-07-29
Primary completion: 2027-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.